Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling

J. Masia, D. Bordoni, G. Pons, C. Liuzza, F. Castagnetti, G. Falco

Research output: Contribution to journalArticle

Abstract

Background: Autologous fat grafting is a widely accepted approach for breast reconstruction after mastectomy but its oncological safety has not been established. This study aimed to compare recurrence in patients who underwent fat-grafting procedures after autologous breast reconstruction and those who did not. Patients and methods: We retrospectively reviewed 207 consecutive patients, who underwent mastectomy and reconstruction using free flap surgery. We divide them in two groups: a study group of patients who underwent fat grafting procedure and a control group of patients who did not. Outcome regarding local and regional recurrence was compared between the two groups. Particularly, we studied recurrences from primary surgery to baseline (first lipofilling) and from baseline to most recent follow-up. Results: Median follow-up was 60 months from surgery to baseline and 29 months from baseline to most recent follow-up. The overall observational period after mastectomy in the control group was 120 months. Local recurrence was observed in 6 patients from the study group, respectively 3 in the first observational period and 3 after the fat grafting procedure. The control group, as the study one, presented a total of 6 recurrences (p = 0.555; Hazard Ratio free flap and lipo vs only free flap: = 0.66; 95% CI 0.16-2.66). Conclusions: We found no significant differences in recurrence between patients who underwent fat grafting and those who did not. These encouraging findings support previous results but larger series of patients are required to confirm long-term oncological safety in these procedures.

Original languageEnglish
Pages (from-to)612-616
Number of pages5
JournalEuropean Journal of Surgical Oncology
Volume41
Issue number5
DOIs
Publication statusPublished - 2015

Fingerprint

Free Tissue Flaps
Breast Neoplasms
Safety
Recurrence
Fats
Mastectomy
Mammaplasty
Control Groups

Keywords

  • Fat grafting
  • Free-flap
  • Recurrences

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Medicine(all)

Cite this

Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling. / Masia, J.; Bordoni, D.; Pons, G.; Liuzza, C.; Castagnetti, F.; Falco, G.

In: European Journal of Surgical Oncology, Vol. 41, No. 5, 2015, p. 612-616.

Research output: Contribution to journalArticle

@article{cf8b6a13e6c840bf8f69679a1944f12e,
title = "Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling",
abstract = "Background: Autologous fat grafting is a widely accepted approach for breast reconstruction after mastectomy but its oncological safety has not been established. This study aimed to compare recurrence in patients who underwent fat-grafting procedures after autologous breast reconstruction and those who did not. Patients and methods: We retrospectively reviewed 207 consecutive patients, who underwent mastectomy and reconstruction using free flap surgery. We divide them in two groups: a study group of patients who underwent fat grafting procedure and a control group of patients who did not. Outcome regarding local and regional recurrence was compared between the two groups. Particularly, we studied recurrences from primary surgery to baseline (first lipofilling) and from baseline to most recent follow-up. Results: Median follow-up was 60 months from surgery to baseline and 29 months from baseline to most recent follow-up. The overall observational period after mastectomy in the control group was 120 months. Local recurrence was observed in 6 patients from the study group, respectively 3 in the first observational period and 3 after the fat grafting procedure. The control group, as the study one, presented a total of 6 recurrences (p = 0.555; Hazard Ratio free flap and lipo vs only free flap: = 0.66; 95{\%} CI 0.16-2.66). Conclusions: We found no significant differences in recurrence between patients who underwent fat grafting and those who did not. These encouraging findings support previous results but larger series of patients are required to confirm long-term oncological safety in these procedures.",
keywords = "Fat grafting, Free-flap, Recurrences",
author = "J. Masia and D. Bordoni and G. Pons and C. Liuzza and F. Castagnetti and G. Falco",
year = "2015",
doi = "10.1016/j.ejso.2015.02.008",
language = "English",
volume = "41",
pages = "612--616",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling

AU - Masia, J.

AU - Bordoni, D.

AU - Pons, G.

AU - Liuzza, C.

AU - Castagnetti, F.

AU - Falco, G.

PY - 2015

Y1 - 2015

N2 - Background: Autologous fat grafting is a widely accepted approach for breast reconstruction after mastectomy but its oncological safety has not been established. This study aimed to compare recurrence in patients who underwent fat-grafting procedures after autologous breast reconstruction and those who did not. Patients and methods: We retrospectively reviewed 207 consecutive patients, who underwent mastectomy and reconstruction using free flap surgery. We divide them in two groups: a study group of patients who underwent fat grafting procedure and a control group of patients who did not. Outcome regarding local and regional recurrence was compared between the two groups. Particularly, we studied recurrences from primary surgery to baseline (first lipofilling) and from baseline to most recent follow-up. Results: Median follow-up was 60 months from surgery to baseline and 29 months from baseline to most recent follow-up. The overall observational period after mastectomy in the control group was 120 months. Local recurrence was observed in 6 patients from the study group, respectively 3 in the first observational period and 3 after the fat grafting procedure. The control group, as the study one, presented a total of 6 recurrences (p = 0.555; Hazard Ratio free flap and lipo vs only free flap: = 0.66; 95% CI 0.16-2.66). Conclusions: We found no significant differences in recurrence between patients who underwent fat grafting and those who did not. These encouraging findings support previous results but larger series of patients are required to confirm long-term oncological safety in these procedures.

AB - Background: Autologous fat grafting is a widely accepted approach for breast reconstruction after mastectomy but its oncological safety has not been established. This study aimed to compare recurrence in patients who underwent fat-grafting procedures after autologous breast reconstruction and those who did not. Patients and methods: We retrospectively reviewed 207 consecutive patients, who underwent mastectomy and reconstruction using free flap surgery. We divide them in two groups: a study group of patients who underwent fat grafting procedure and a control group of patients who did not. Outcome regarding local and regional recurrence was compared between the two groups. Particularly, we studied recurrences from primary surgery to baseline (first lipofilling) and from baseline to most recent follow-up. Results: Median follow-up was 60 months from surgery to baseline and 29 months from baseline to most recent follow-up. The overall observational period after mastectomy in the control group was 120 months. Local recurrence was observed in 6 patients from the study group, respectively 3 in the first observational period and 3 after the fat grafting procedure. The control group, as the study one, presented a total of 6 recurrences (p = 0.555; Hazard Ratio free flap and lipo vs only free flap: = 0.66; 95% CI 0.16-2.66). Conclusions: We found no significant differences in recurrence between patients who underwent fat grafting and those who did not. These encouraging findings support previous results but larger series of patients are required to confirm long-term oncological safety in these procedures.

KW - Fat grafting

KW - Free-flap

KW - Recurrences

UR - http://www.scopus.com/inward/record.url?scp=84931461945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931461945&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2015.02.008

DO - 10.1016/j.ejso.2015.02.008

M3 - Article

C2 - 25800344

AN - SCOPUS:84931461945

VL - 41

SP - 612

EP - 616

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 5

ER -